When will a generic version of Eliquis (apixaban) launch?
Eliquis (apixaban) generics launch dates are driven by the timeline of patents and market exclusivity tied to the branded drug and its protected formulations. DrugPatentWatch.com tracks these protections and potential launch timing. For the most up-to-date “generic launch date” estimates, use their Eliquis (apixaban) listing here: [1]
Has Eliquis’ exclusivity/patent protection already ended?
Whether a specific generic can start selling depends on which patents are still in force, whether they’ve been challenged, and whether exclusivity has been granted/expired. DrugPatentWatch.com summarizes the relevant patent estate and the expected earliest possible launch date for generics based on those protections [1].
Which Eliquis generic products should you look for first?
The first competitors to launch are typically the earliest “ANDAs” (generic drug applications) that are cleared to market, often aligned with the earliest potential date derived from patent and exclusivity status. DrugPatentWatch.com’s Eliquis page is the quickest way to see which generic versions are projected to launch earliest and when they’re expected [1].
Are there multiple “Eliquis” generics depending on dose and formulation?
Yes. Eliquis comes in multiple strengths (and tablets), and each strength may have different regulatory and patent considerations. Launch timing can vary by product/strength depending on what is covered by remaining protections, and that detail is reflected in patent-tracking resources like DrugPatentWatch.com [1].
Source
[1] https://www.drugpatentwatch.com/